Industry Insights
-
FDA Warns Industry Of Fraudulent & Unreliable Lab Testing Data In Premarket Submissions
4/11/2024
The FDA recently announced that they have seen an increase in the number of entities that contract out testing or services where the data provided by said firms was fabricated, duplicated, or just deemed “unreliable.” Here's what you can do.
-
Future Clinical Trials: Embracing Standardization And Automation
4/10/2024
Through standardized protocols and automation integration, uncover how the industry is poised to unlock new levels of productivity and innovation, advancing the development of safe and effective treatments for patients worldwide.
-
The Impact Of RWD And Cloud Tech On Research, Health Outcomes
4/10/2024
Far too often, valuable data sources are siloed, disparate, and unusable. Learn how expansive datasets can empower the industry to advance clinical trials and outcomes research, benefiting all communities.
-
Trends Shaping The Pharmaceutical Industry's Future
4/10/2024
Decentralized trials and patient choice are key to expanding clinical trial reach. Through diverse options and AI-powered connections across health systems and community sites, learn how patient access increases.
-
Something To Believe In — AI And Accelerated Computing In Healthcare
4/10/2024
See how the advancements in supercomputing, high-performance networking, and cloud technology are paving the way for unprecedented levels of innovation and creativity in this field.
-
ICH E6(R3) And Defining What Is Critical To TMF Quality
4/9/2024
By applying Quality by Design to clinical trials, sponsor companies can rise to meet the elevated role and importance of the TMF in the face of ICH E6 (RF3).
-
2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
4/9/2024
Clarkston Consulting conducted its third annual Chief Information Officer (CIO) Survey to understand IT budgets of life sciences companies, how AI priorities fit into those budgets, and more.
-
Insights Into The Clinical Trials Landscape Of CL
4/8/2024
Uncover developments in cystic fibrosis treatment, focusing on innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Global Prevalence And Clinical Trials Landscape Of AML
4/8/2024
Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Mobile Visits Are Key To Decentralizing Rare Disease Research
4/8/2024
Discover how mobile visits revolutionize rare disease research, bridging gaps in clinical trial accessibility and enhancing patient engagement for conditions like Rett Syndrome.